What's the reason for drawing regular before NPH?
-
CycleTrack and SDN are teaming up to make medical school admissions more transparent and accessible! Read the announcement to learn how we’re supporting the future of CycleTrack’s free application-tracking tools .
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
Clear before Cloudy
Started by Pharmacy Kid
Get help with your application
Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.
I don't know, but when I utilized the most reliable of all search methods (google 😉), I came across a diabetes help forum where someone had the username "Cinnabon." 
If I had to guess though (after a little bit of digging), I would say it is because if you introduce the protamine component from the NPH into the regular insulin vial, you have effectively transformed a small portion of your fast-acting insulin to intermediate acting insulin (since it's an association of insulin with the protamine that causes the increased duration - if I recall insulin pharmacology correctly)? Whereas if you introduce regular insulin into a solution of NPH, regular insulin associating w/ protamine would have really no effect (it's already an intermediate acting insulin after all).
Hopefully someone w/ a greater knowledge base in pharmacology will respond. I just had to share about "Cinnabon" and felt like it was important to add something meaningful to the discussion as well.

If I had to guess though (after a little bit of digging), I would say it is because if you introduce the protamine component from the NPH into the regular insulin vial, you have effectively transformed a small portion of your fast-acting insulin to intermediate acting insulin (since it's an association of insulin with the protamine that causes the increased duration - if I recall insulin pharmacology correctly)? Whereas if you introduce regular insulin into a solution of NPH, regular insulin associating w/ protamine would have really no effect (it's already an intermediate acting insulin after all).
Hopefully someone w/ a greater knowledge base in pharmacology will respond. I just had to share about "Cinnabon" and felt like it was important to add something meaningful to the discussion as well.
This is more or less what I was taught, although not necessarily due to protamine (you would use the rapid before Lantus, too). I believe it's mainly the fact that you're putting something with a longer duration into a vial that's supposed to be short acting, so you could get a peak at the wrong time and end up bottoming out.If I had to guess though (after a little bit of digging), I would say it is because if you introduce the protamine component from the NPH into the regular insulin vial, you have effectively transformed a small portion of your fast-acting insulin to intermediate acting insulin (since it's an association of insulin with the protamine that causes the increased duration - if I recall insulin pharmacology correctly)? Whereas if you introduce regular insulin into a solution of NPH, regular insulin associating w/ protamine would have really no effect (it's already an intermediate acting insulin after all).
Also with the cloudy NPH, if you get some of that into your rapid, it would probably make the whole vial cloudy, so that's obviously not desirable.
I don't think you're supposed to mix lantus.This is more or less what I was taught, although not necessarily due to protamine (you would use the rapid before Lantus, too). I believe it's mainly the fact that you're putting something with a longer duration into a vial that's supposed to be short acting, so you could get a peak at the wrong time and end up bottoming out.
Also with the cloudy NPH, if you get some of that into your rapid, it would probably make the whole vial cloudy, so that's obviously not desirable.